These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12829830)

  • 1. Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner.
    Strähle L; Garcin D; Le Mercier P; Schlaak JF; Kolakofsky D
    J Virol; 2003 Jul; 77(14):7903-13. PubMed ID: 12829830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not toll-like receptor 3.
    Elco CP; Guenther JM; Williams BR; Sen GC
    J Virol; 2005 Apr; 79(7):3920-9. PubMed ID: 15767394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.
    Yoshida A; Kawabata R; Honda T; Sakai K; Ami Y; Sakaguchi T; Irie T
    J Virol; 2018 Mar; 92(5):. PubMed ID: 29237838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sendai virus C protein inhibits lipopolysaccharide-induced nitric oxide production through impairing interferon-β signaling.
    Odkhuu E; Komatsu T; Naiki Y; Koide N; Yokochi T
    Int Immunopharmacol; 2014 Nov; 23(1):267-72. PubMed ID: 25242386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paramyxovirus Sendai virus V protein counteracts innate virus clearance through IRF-3 activation, but not via interferon, in mice.
    Kiyotani K; Sakaguchi T; Kato A; Nagai Y; Yoshida T
    Virology; 2007 Mar; 359(1):82-91. PubMed ID: 17027894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the beta interferon promoter by unnatural Sendai virus infection requires RIG-I and is inhibited by viral C proteins.
    Strähle L; Marq JB; Brini A; Hausmann S; Kolakofsky D; Garcin D
    J Virol; 2007 Nov; 81(22):12227-37. PubMed ID: 17804509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis.
    Kato A; Ohnishi Y; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2001 Apr; 75(8):3802-10. PubMed ID: 11264369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus 1 has multiple mechanisms for blocking virus-induced interferon production.
    Melroe GT; DeLuca NA; Knipe DM
    J Virol; 2004 Aug; 78(16):8411-20. PubMed ID: 15280450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.
    Garcin D; Latorre P; Kolakofsky D
    J Virol; 1999 Aug; 73(8):6559-65. PubMed ID: 10400752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human parainfluenza virus type 1 but not Sendai virus replicates in human respiratory cells despite IFN treatment.
    Bousse T; Chambers RL; Scroggs RA; Portner A; Takimoto T
    Virus Res; 2006 Oct; 121(1):23-32. PubMed ID: 16677733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The amino-terminal half of Sendai virus C protein is not responsible for either counteracting the antiviral action of interferons or down-regulating viral RNA synthesis.
    Kato A; Ohnishi Y; Hishiyama M; Kohase M; Saito S; Tashiro M; Nagai Y
    J Virol; 2002 Jul; 76(14):7114-24. PubMed ID: 12072511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus Multiplicity of Infection Affects Type I Interferon Subtype Induction Profiles and Interferon-Stimulated Genes.
    Zaritsky LA; Bedsaul JR; Zoon KC
    J Virol; 2015 Nov; 89(22):11534-48. PubMed ID: 26355085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longer and shorter forms of Sendai virus C proteins play different roles in modulating the cellular antiviral response.
    Garcin D; Curran J; Itoh M; Kolakofsky D
    J Virol; 2001 Aug; 75(15):6800-7. PubMed ID: 11435558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.
    Qi D; Hu L; Jiao T; Zhang T; Tong X; Ye X
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30021902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of the anti-interferon capacity of Sendai virus C protein for pathogenicity in mice.
    Kato A; Kiyotani K; Kubota T; Yoshida T; Tashiro M; Nagai Y
    J Virol; 2007 Apr; 81(7):3264-71. PubMed ID: 17215288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulation of interferon-β gene expression during acute and persistent virus infections.
    Ye J; Maniatis T
    PLoS One; 2011; 6(6):e20681. PubMed ID: 21677781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the amino acid residues of sendai virus C protein that are critically involved in its interferon antagonism and RNA synthesis down-regulation.
    Kato A; Cortese-Grogan C; Moyer SA; Sugahara F; Sakaguchi T; Kubota T; Otsuki N; Kohase M; Tashiro M; Nagai Y
    J Virol; 2004 Jul; 78(14):7443-54. PubMed ID: 15220418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C and V proteins of Sendai virus target signaling pathways leading to IRF-3 activation for the negative regulation of interferon-beta production.
    Komatsu T; Takeuchi K; Yokoo J; Gotoh B
    Virology; 2004 Jul; 325(1):137-48. PubMed ID: 15231393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products.
    Chambers R; Takimoto T
    J Gen Virol; 2009 Aug; 90(Pt 8):1906-1915. PubMed ID: 19423549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The amino-terminal extensions of the longer Sendai virus C proteins modulate pY701-Stat1 and bulk Stat1 levels independently of interferon signaling.
    Garcin D; Marq JB; Goodbourn S; Kolakofsky D
    J Virol; 2003 Feb; 77(4):2321-9. PubMed ID: 12551969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.